(NASDAQ: YARW) Yarrow Bioscience's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.93%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.54%.
Yarrow Bioscience's earnings in 2026 is -$18,709,000.On average, 4 Wall Street analysts forecast YARW's earnings for 2026 to be -$4,847,191, with the lowest YARW earnings forecast at -$5,520,501, and the highest YARW earnings forecast at -$4,064,688. On average, 4 Wall Street analysts forecast YARW's earnings for 2027 to be -$115,542,869, with the lowest YARW earnings forecast at -$215,848,964, and the highest YARW earnings forecast at -$6,615,631.
In 2028, YARW is forecast to generate -$5,173,968 in earnings, with the lowest earnings forecast at -$4,971,067 and the highest earnings forecast at -$5,326,143.